Cite
HARVARD Citation
Nywening, T. et al. (2018). Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. Gut. 67 (6), pp. 1112-1123. [Online].